Innovent Biologics and Spero Therapeutics Announce Exclusive License for IBI355 (SP001), a Phase 2-Ready Third-Generation Anti-CD40L Antibody

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Innovent Biologics and Spero Therapeutics Announce Exclusive License for IBI355 (SP001), a Phase 2-Ready Third-Generation Anti-CD40L Antibody
(AMEX: IVBIY) Delayed: 54.29 --0 (-0%)
Previous Close $54.29    52 Week High $ 
Open $54.29    52 Week Low $ 
Day High $54.29    P/E N/A 
Day Low $54.29    EPS $ 
Volume 5,424       

SmartPros Ltd. (NASDAQ: SPRO) Delayed: 1.12 +0.01 (0.90%)
Previous Close $1.11    52 Week High $3.85 
Open $1.14    52 Week Low $1.25 
Day High $1.14    P/E N/A 
Day Low $1.11    EPS $-0.28 
Volume 181,128